Home
Home » Monthly archive

March 2011

Dividend Sector Review: Pharmaceuticals

Dividend Sector Review: Pharmaceuticals
Motley Fool

Omeros says knee drug didn't meet goal in ACL surgery study, shares plunge after hours

Omeros says knee drug didn't meet goal in ACL surgery study, shares plunge after hours
Yahoo/AP

Better Buy? Seattle Genetics or ImmunoGen

Better Buy? Seattle Genetics or ImmunoGen
Motley Fool

J&J Loses Bid to Overturn $482 Million Patent Verdict

J&J Loses Bid to Overturn $482 Million Patent Verdict
Bloomberg

Peering Into Pfizer’s Future

Peering Into Pfizer’s Future
Forbes

Biotech Fever Spreads

Biotech Fever Spreads
Forbes

BioSante's Potential Blockbuster Treatment

BioSante's Potential Blockbuster Treatment
Seeking Alpha

Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in midstage study

Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in midstage study
Yahoo/AP

Pharmasset Hepatitis C Drug Combination Helped 98% of Patients

Pharmasset Hepatitis C Drug Combination Helped 98% of Patients
Bloomberg

Valeant's Surprise Bid for Cephalon: Repeating a Growth Trick?

Valeant's Surprise Bid for Cephalon: Repeating a Growth Trick?
Seeking Alpha